World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
88
Citations
27878
World Ranking
13181
National Ranking
6717

David H. Abramson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where David H. Abramson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 635 publications — 75th percentile

75% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

David H. Abramson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where David H. Abramson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 88 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

David H. Abramson is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research primarily spans the field of Medicine, with significant work in Ophthalmology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research, and Molecular Biology. Abramson's contributions have focused extensively on ocular oncology and treatments, cancer-related molecular pathways, cancer genomics and diagnostics, brain metastases and treatment, glioma diagnosis and treatment, neuroblastoma research and treatments, and histiocytic disorders and treatments.

Their recent publications reflect a focus on cancer genomics, pediatric solid tumors, retinoblastoma, and melanoma progression. Notable papers include:

  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors (2021, Nature Cancer)
  • Treatment of Retinoblastoma: What Is the Latest and What Is the Future (2022, Frontiers in Oncology)
  • Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression (2021, Nature Communications)
  • Cell-free DNA profiling in retinoblastoma patients with advanced intraocular disease: An MSKCC experience (2020, Cancer Medicine)
  • Immune Checkpoint Inhibitor-Associated Optic Neuritis (2020, Ophthalmology)

Frequent co-authors collaborating with Abramson include:

  • Jasmine H. Francis
  • Julia Canestraro
  • Ira J. Dunkel
  • Guillermo Chantada
  • Y. Pierre Gobin

These collaborations have contributed to a substantial publication record, especially in well-known clinical and research journals. Among the most common publication venues are:

  • Ophthalmology
  • Journal of Pediatric Ophthalmology & Strabismus
  • Pediatric Blood & Cancer
  • Ophthalmology Retina
  • American Journal of Ophthalmology Case Reports

Abramson's work is centered around clinical and molecular aspects of ocular and pediatric cancers, emphasizing early detection, treatment modalities, and molecular diagnostics. Their research intersects multiple disciplines including ophthalmology and oncology, highlighting translational applications in pediatric oncology and ocular cancer treatments. The volume and diversity of Abramson's publications indicate a broad engagement with both clinical and laboratory research communities, addressing complex cancer-related molecular pathways and therapeutic approaches.

Best Publications

  • Cancer Incidence After Retinoblastoma: Radiation Dose and Sarcoma Risk

    FL Wong;JD Boice;DH Abramson;RE Tarone

  • Germline mutations in BAP1 predispose to melanocytic tumors

    Thomas Wiesner;Anna C Obenauf;Anna C Obenauf;Rajmohan Murali;Isabella Fried

  • Mortality From Second Tumors Among Long-Term Survivors of Retinoblastoma

    Charis Eng;Frederick P. Li;David H. Abramson;Robert M. Ellsworth

  • Second Nonocular Tumors in Retinoblastoma Survivors: Are They Radiation-induced?

    Abramson Dh;Ellsworth Rm;Kitchin Fd;Tung G

  • A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.

    David H. Abramson;David H. Abramson;Ira J. Dunkel;Scott E. Brodie;Scott E. Brodie;Scott E. Brodie;Jonathan W. Kim

  • Risk of New Cancers After Radiotherapy in Long-Term Survivors of Retinoblastoma: An Extended Follow-Up

    Ruth A. Kleinerman;Margaret A. Tucker;Robert E. Tarone;David H. Abramson

  • Intra-arterial Chemotherapy for the Management of Retinoblastoma: Four-Year Experience

    Y. Pierre Gobin;Ira J. Dunkel;Brian P. Marr;Scott E. Brodie

  • Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial

    Richard D. Carvajal;Jeffrey A. Sosman;Jorge Fernando Quevedo;Mohammed M. Milhem

  • Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk.

    David H Abramson;Christopher M Frank

  • Presenting signs of retinoblastoma

    David H. Abramson;Christopher M. Frank;Mark Susman;Mary P. Whalen

  • Variates of survival in metastatic uveal melanoma.

    Petra Rietschel;Katherine S. Panageas;Christine Hanlon;Ami Patel

  • Update on retinoblastoma.

    David H Abramson;Amy C Schefler

  • Collaborative ocular melanoma study (COMS) randomized trial of I-125 brachytherapy for medium choroidal melanoma: I. visual acuity after 3 years COMS report no. 16

    B. M. Melia;D. H. Abramson;D. M. Albert;H. C. Boldt

  • Nonocular cancer in retinoblastoma survivors.

    Abramson Dh;Ellsworth Rm;Zimmerman Le

  • Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

    B L Gallie;R M Ellsworth;D H Abramson;R A Phillips

  • Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival.

    David H Abramson;Katherine Beaverson;Poorab Sangani;Robin A Vora

  • Treatment of Retinoblastoma in 2015: Agreement and Disagreement

    David H. Abramson;Carol L. Shields;Francis L. Munier;Guillermo L. Chantada

  • Risk of Soft Tissue Sarcomas by Individual Subtype in Survivors of Hereditary Retinoblastoma

    Ruth A. Kleinerman;Margaret A. Tucker;David H. Abramson;Johanna M. Seddon

  • Superselective Ophthalmic Artery Chemotherapy as Primary Treatment for Retinoblastoma (Chemosurgery)

    David H. Abramson;Ira J. Dunkel;Scott E. Brodie;Brian Marr

  • Mortality from Second Tumors Among Long-Term Survivors of Retinoblastoma

    C. Eng;F. P. Li;D. H. Abramson;R. M. Ellsworth

Frequent Co-Authors

Johanna M. Seddon
Johanna M. Seddon University of Massachusetts Chan Medical School
Suresh C. Jhanwar
Suresh C. Jhanwar Memorial Sloan Kettering Cancer Center
Margaret A. Tucker
Margaret A. Tucker National Institutes of Health
Kevin C. Oeffinger
Kevin C. Oeffinger Duke University
Paul B. Chapman
Paul B. Chapman Memorial Sloan Kettering Cancer Center
Michael F. Berger
Michael F. Berger Memorial Sloan Kettering Cancer Center
Richard D. Carvajal
Richard D. Carvajal Columbia University
Jedd D. Wolchok
Jedd D. Wolchok Cornell University
Francis L. Munier
Francis L. Munier University of Lausanne
Carol L. Shields
Carol L. Shields Thomas Jefferson University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or supportive roles, there is a wide range of online degrees and career pathways in healthcare. From hands-on patient care to administrative specialties, online programs offer flexibility and affordability to meet different needs and goals.

Entry points such as medical billing and coding cost courses allow students to quickly enter healthcare administration by learning to manage medical records and insurance claims. For those aiming to become advanced clinicians, finding affordable np programs is essential to balance quality education with financial responsibility.

Nursing remains one of the most versatile fields, and affordable online nursing programs can lead to rewarding careers with strong job security. Ambitious nurses looking to advance can consider a doctorate in nursing education online programs, opening doors to leadership, research, or academic roles.

Exploring these online options can help prospective students chart a fulfilling path in the healthcare sector, whether as clinicians, educators, or healthcare administrators.

Best Scientists Citing David H. Abramson

Trending Scientists

Recently Published Articles